Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Ascendis Pharma A/S

Ascendis Pharma A/S (ASND)

Market is closed
News
Here's Why Artisan Partners Increased its Ascendis Pharma (ASND) Position

Here's Why Artisan Partners Increased its Ascendis Pharma (ASND) Position

Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ third quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

November 23rd, 2021 - Hedge Fund Investor Letters News

Here is What Hedge Funds Think About Ascendis Pharma A/S (ASND)

Here is What Hedge Funds Think About Ascendis Pharma A/S (ASND)

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...

Keep Reading →

October 18th, 2021 - Hedge Funds News

Is Ascendis Pharma A/S (ASND) A Good Stock To Buy?

Is Ascendis Pharma A/S (ASND) A Good Stock To Buy?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

July 12th, 2021 - Hedge Funds News

Should You Consider Investing in Ascendis Pharma (ASND)?

Should You Consider Investing in Ascendis Pharma (ASND)?

Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

May 6th, 2021 - Hedge Fund Investor Letters News

Is ASND Stock A Buy or Sell?

Is ASND Stock A Buy or Sell?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...

Keep Reading →

April 19th, 2021 - Hedge Funds News

Free Stock Pick From Insider Monkey's Monthly Newsletter

Free Stock Pick From Insider Monkey's Monthly Newsletter

Our premium monthly newsletter costs $449 annually and features my personal stock picks.

Keep Reading →

October 8th, 2020 - Economy Macroeconomic Predictions News

Is Ascendis Pharma A/S (ASND) Going to Burn These Hedge Funds?

Is Ascendis Pharma A/S (ASND) Going to Burn These Hedge Funds?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

September 15th, 2020 - Hedge Funds News

Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case

Why Ascendis Pharma (ASND) Stock is a Compelling Investment Case

Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here.

Keep Reading →

July 24th, 2020 - Hedge Fund Investor Letters News

Did Hedge Funds Make The Right Call On Ascendis Pharma A/S (ASND) ?

Did Hedge Funds Make The Right Call On Ascendis Pharma A/S (ASND) ?

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Keep Reading →

July 10th, 2020 - Hedge Funds News

Should You Avoid Ascendis Pharma A/S (ASND)?

Should You Avoid Ascendis Pharma A/S (ASND)?

In this article we will check out the progression of hedge fund sentiment towards Ascendis Pharma A/S (NASDAQ:ASND) and determine whether it is a good investment right now.

Keep Reading →

June 3rd, 2020 - Hedge Funds News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)